These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 10297481)

  • 1. The formulary system revisited.
    Lantos RL
    Hosp Formul; 1979 Jun; 14(6):664, 662. PubMed ID: 10297481
    [No Abstract]   [Full Text] [Related]  

  • 2. The formulary system: brief history and 1960s perspective. Excerpted from Mirror to Hospital Pharmacy. 1964.
    Am J Hosp Pharm; 1986 Nov; 43(11):2838-9. PubMed ID: 3541585
    [No Abstract]   [Full Text] [Related]  

  • 3. ASHP guidelines on formulary system management.
    Am J Hosp Pharm; 1992 Mar; 49(3):648-52. PubMed ID: 1598948
    [No Abstract]   [Full Text] [Related]  

  • 4. Does your committee pass the McNemar test?
    Owen JA
    Hosp Formul; 1979 Jun; 14(6):605. PubMed ID: 10242200
    [No Abstract]   [Full Text] [Related]  

  • 5. The formulary system: product of the teaching hospital.
    Francke DE
    Hospitals; 1967 Nov; 41(22):110 passim. PubMed ID: 6062395
    [No Abstract]   [Full Text] [Related]  

  • 6. Formulary management to reduce cost: P & T committee strategies.
    Roberts MJ; Summerfield MR
    Hosp Formul; 1986 Apr; 21(4):481-3, 488-92. PubMed ID: 10276289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How drugs attain formulary listing.
    Rolands TF; Williams RB
    Hospitals; 1975 Jan; 49(2):87-9. PubMed ID: 1088948
    [No Abstract]   [Full Text] [Related]  

  • 8. P & T committees and the hospital formulary.
    Evans PJ; Standish RC; Bell JE
    Hosp Formul; 1983 Sep; 18(9):892-5. PubMed ID: 10262367
    [No Abstract]   [Full Text] [Related]  

  • 9. A survey of selective administration procedures in formulary maintenance.
    Quigley MA; Brown WM
    Hosp Pharm; 1981 Jul; 15(7):371-4, 378-80. PubMed ID: 10252001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementing and maintaining a viable formulary.
    Kelly WN; Bender FH
    Hosp Formul; 1983 Oct; 18(10):976-8, 981-2, 987. PubMed ID: 10262828
    [No Abstract]   [Full Text] [Related]  

  • 11. The foremost problems associated with formulary management.
    Davis NM
    Hosp Pharm; 1983 Mar; 18(3):131, 134-5. PubMed ID: 10260204
    [No Abstract]   [Full Text] [Related]  

  • 12. Prospective reimbursement and DRGs: implications for formulary management.
    Enright SM
    Hosp Formul; 1983 Oct; 18(10):989-90, 999-1000. PubMed ID: 10310246
    [No Abstract]   [Full Text] [Related]  

  • 13. ASHP technical assistance bulletin on assessing cost-containment strategies for institutional pharmacies.
    Am J Hosp Pharm; 1985 Jul; 42(7):1583-91. PubMed ID: 4025363
    [No Abstract]   [Full Text] [Related]  

  • 14. The formulary decision-making process in a US academic medical centre.
    Nash DB; Catalano ML; Wordell CJ
    Pharmacoeconomics; 1993 Jan; 3(1):22-35. PubMed ID: 10146985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What should your formulary look like?
    Lanser EG
    Healthc Exec; 2002; 17(1):52. PubMed ID: 11822245
    [No Abstract]   [Full Text] [Related]  

  • 16. Raising the bar in the formulary decision process.
    Navarro RP
    Manag Care Interface; 1999 Jul; 12(7):51, 54. PubMed ID: 10539501
    [No Abstract]   [Full Text] [Related]  

  • 17. History and status of the ASHP drug coding and listing services.
    Provost GP
    Am J Hosp Pharm; 1968 Jan; 25(1):12-9. PubMed ID: 4867618
    [No Abstract]   [Full Text] [Related]  

  • 18. Hospitals defend formulary decisions against industry attacks.
    Talley CR
    Am J Hosp Pharm; 1978 Sep; 35(9):1154-5. PubMed ID: 696756
    [No Abstract]   [Full Text] [Related]  

  • 19. P & T Committee formulary requests: criteria for admission.
    Weintraub M; Guttmacher L
    Hosp Formul; 1984 Oct; 19(10):975-7, 980. PubMed ID: 10268315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guidelines on the operation of the pharmacy and therapeutics committee and formulary.
    Linkewich JA; Prevoznik SJ
    Hosp Pharm; 1979 Jan; 14(1):7-10, 13, 16-9 passim. PubMed ID: 10240149
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.